 鲜花( 85)  鸡蛋( 2)
|

楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
: H7 O, d7 [0 [# E$ N: C
: {6 w" n8 G/ e0 e) EEDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX. _. [) h6 N: t( m& @1 j; T* F
7 a5 _, g+ t2 b/ w8 x, \( V- [
BY THE EDMONTON JOURNAL FEBRUARY 16, 20070 f) S1 X X+ f* X8 j1 o) `
' o0 P, J3 k+ `1 E p# m
' A" F$ a: e: ~# r" r7 c
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
4 M1 {' E3 g/ U4 s, ^9 y% U$ B* {/ P
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
0 _6 F$ D+ c3 h% c4 N/ W( C; l0 [: j0 M1 d: Q2 \8 K- b
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
1 f: o" i$ @) y. k5 l1 P; ~8 c, H- a3 B \( U, E
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
2 k2 ^, w# ~' L: m
0 u% \5 G4 X ~2 _, m- l; |/ fIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
6 O" ?/ z( p* f z$ q9 V- W$ T+ O# `( q
"As a scientist, it's one of the highlights of my CAREER," Shan said.
. q V4 j- L; H
4 H5 f$ |) K: @1 F"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
+ v7 u( J( g1 J% }9 S4 G6 ^% u/ k6 z) O+ h; v
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
( H: `# B* T2 F5 U* n$ D' K! w
+ v8 A, M& d* f/ CGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
( y" ]* g7 N& D1 h6 f% u& [4 _4 _* w6 Z+ m- `! Z7 y1 K2 q
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
- D3 X5 X! `" h* y" J4 }4 i% i: S& u
& r% n9 b6 `6 t1 u3 m' N, ?+ v, P/ z
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|